InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Hoelscher Paul W., Chief Financial Officer. Director active across 1 companies, notably Horizon Therapeutics Public Ltd Co. Aggregated, 13 filings have been logged. Total volume traded: €15.3m. The latest transaction was disclosed on 20 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€1m50,000 shares@ €20.40586.1% of flow
Ordinary Shares
SEC:0001209191-22-025455:0·
€443,36530,275 shares@ €14.64462.6% of flow
Ordinary Shares
SEC:0001209191-22-023845:0·
066,626 shares0
Ordinary Shares
SEC:0001209191-22-021151:0·
05,558 shares0
Ordinary Shares
SEC:0001209191-22-004633·
05,558 shares0
Ordinary Shares
SEC:0001209191-22-004633:0·
66,822 shares
Ordinary Shares
SEC:0001209191-22-002291·
66,822 shares
Ordinary Shares
SEC:0001209191-22-002291:0·
06,163 shares0
Ordinary Shares
SEC:0001209191-21-071650·
06,163 shares0
Ordinary Shares
SEC:0001209191-21-071650:0·
08,708 shares0
Ordinary Shares
SEC:0001209191-21-048788·
08,708 shares0
Ordinary Shares
SEC:0001209191-21-048788:0·
€8m102,925 shares@ €74.5248100.0% of flow
Ordinary Shares
SEC:0001209191-21-032882·
€8m102,925 shares@ €74.524845.6% of flow
Ordinary Shares
SEC:0001209191-21-032882:0·
13 of 13 declarations
About Hoelscher Paul W.
Hoelscher Paul W. serves as CFO at Horizon Therapeutics Public Ltd Co. He is responsible for the financial management of the company, including budgeting and performance analysis. His expertise is essential for ensuring the financial health and growth of the organization.
